Bartolo Colon suspended 50 games for testosterone

110 Comments

Melky Cabrera has company.

MLB just announced that A’s right-hander and former Cy Young winner Bartolo Colon has been suspended 50 games after testing positive for testosterone.

Last week Cabrera was suspended for 50 games following a positive test for testosterone in the middle of a career-best season in which he hit .346 with a .906 OPS and won All-Star game MVP honors.

Colon hasn’t had quite that type of impact, but he’s been plenty solid for Oakland on a one-year, $2 million contract with a 3.43 ERA and 91/23 K/BB ratio in 152 innings spread over 24 starts. And now at age 39 it’s safe to wonder if he’s thrown his last pitch in the big leagues.

MLB previously investigated the stem-cell treatment that Colon received two years ago for his elbow in an effort to make it back to the majors after not pitching at all in 2010. He was successful in his comeback and MLB cleared him of any potential performance enhancing-drug violations.

It’s a tough blow for the A’s in the AL West and Wild Card races, but with Brett Anderson looking good in his return from Tommy John surgery last night and Dan Straily waiting in the wings at Triple-A their rotation depth is strong.

UPDATE: Colon won’t be appealing and admitted his guilt via an official statement: “I apologize to the fans, to my teammates and to the Oakland A’s. I accept responsibility for my actions.”

Phillies, Red Sox interested in Carlos Santana

Getty Images
5 Comments

The Phillies and Red Sox appear intent on pursuing free agent first baseman Carlos Santana, MLB Network’s Jon Morosi reports. Santana rejected a one-year, $17.4 million qualifying offer from the Indians on Thursday and is expected to draw widespread interest on the market this winter. The Mets, Mariners, Angels and Indians could make a play for the infielder, though no serious offers have been made this early in the offseason.

Santana, 31, is coming off of a seven-year track with the Indians. He batted .259/.363/.455 with 23 home runs and 3.0 fWAR last season, making 2017 the fourth-most valuable year of his career to date. Although he was primarily stationed at first base over the last year, he could step back into a hybrid first base/DH role with the Red Sox, who are hurting for infield depth with Hanley Ramirez still working his way back from shoulder surgery.

As for Santana’s other suitors, the Mariners are far less likely to pursue a deal after trading for Ryon Healy last Wednesday. Neither the Mets nor the Phillies have a DH spot to offer the veteran infielder, and the Phillies’ Rhys Hoskins appears to be blocking the way at first base. Then again, Santana may not find a more enticing offer outside of Cleveland, where Edwin Encarnacion might otherwise be the club’s best option at first base. During the GM meetings, Indians’ GM Mike Chernoff said he “love to have both [Santana and Jay Bruce] back” in 2018, but hasn’t backed up that love with any contract talks just yet.